2017-2018Foundational research
Research into sperm motility begins, using a mouse model to study swimming behaviour through microchannels.
2019Project MicroFSMA
An MSCA-IF fellowship from the European Commission funds the extension of this navigation study into a human model — achieving deeper insight into tooling that mimics rheotaxis and thermotaxis.
2021Beezbiotech founded
Beezbiotech is officially founded in Rennes, France.
2022EVA takes shape
Incubated via Le Poool and Biotech Santé Bretagne, the lab prototype for EVA technology was initiated and a patent was filed. Love money was secured through Dr. Fassini.
2023Biological validation and capital raise
Capital is raised through stakeholders to advance EVA's biological validation. The lab prototype was validated through the RSM-1 and Inno R&D programmes.
2024MicroBeaCh & growth
A Horizon Europe (MSCA-PF) grant is secured for MicroBeaCh (chemotaxis study); the team expands as Dr. Mehar Un Nissa joins Beezbiotech, which is also admitted to Le Village by CA. Patent protection extends to the EU, US, and China.
2025Pre-seed raise
A pre-seed financing round closes, reflecting strong belief from our business angels in our technology and leadership. The French patent for EVA is granted, and prototype validation expands beyond Rennes.
2026 (Today)Building toward the clinic
Credit is secured from Bpifrance. Dr. Arnaud Maury and Mr. Omar Saubry join the team. The industrial prototype is ready and EVA continues toward pilot-batch validation. See what's next →
